skip to content

Roche’s Virtual Neurology Investor Event

Roche has hosted a virtual event on 11th March 2024.

Agenda
WelcomeBruno Eschli, Head of Investor Relations
Neurology franchise updatePaulo Fontoura, Senior Vice President and Global Head of Neuroscience, Immunology, Ophthalmology, Cardiometabolic, Infectious and Rare Diseases Clinical Development
Review of key EMBARK data presented at MDAAlex Murphy, Senior Clinical Director
Review of key trotinemab and prasinezumab data presented at AD/PDAzad Bonni, MD, PhD, Senior Vice President and Global Head of Neuroscience & Rare Diseases, Roche Pharma Research & Early Development
Questions and answers

Webinar Replay

Investors

Past IR Events
View more Events